Development and validation of a novel LC-MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2017-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jsbmb.2016.04.002PMID 27063554PMCID PMC5124534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I

  2019cited by this paper
• Androgen deprivation therapy for prostate cancer.

  2017cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Redirecting abiraterone metabolism to fine tune prostate cancer anti-androgen therapy

  2016cited by this paper
• Prostate cancer

  2016cited by this paper
• Conversion of abiraterone to D4A drives antitumor activity in prostate cancer

  2015influential reference
• The development of abiraterone acetate for castration-resistant prostate cancer.

  2015cited by this paper
• Use of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancer.

  2014cited by this paper
• Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

  2014cited by this paper
• A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone.

  2014cited by this paper
• Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases.

  2013cited by this paper
• Minireview: Androgen metabolism in castration-resistant prostate cancer.

  2013cited by this paper
• Abiraterone in metastatic prostate cancer without previous chemotherapy.

  2013cited by this paper
• Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval Summary

  2013cited by this paper
• A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects

  2013cited by this paper
• Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.

  2012cited by this paper
• Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer.

  2012cited by this paper
• Abiraterone and increased survival in metastatic prostate cancer.

  2011cited by this paper
• Abiraterone and increased survival in metastatic prostate cancer.

  2011cited by this paper
• Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

  2008cited by this paper
• Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis.

  2005cited by this paper
• Androgen deprivation therapy for prostate cancer.

  2005cited by this paper
• United States Food and Drug Administration Drug Approval Summary

  2004cited by this paper
• The 16,17-double bond is needed for irreversible inhibition of human cytochrome p45017alpha by abiraterone (17-(3-pyridyl)androsta-5, 16-dien-3beta-ol) and related steroidal inhibitors.

  1998cited by this paper
• Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer.

  1995cited by this paper
• Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene.

  1992cited by this paper
• Cancer statistics

  1989cited by this paper

• Overview And Analytical Methods For Determination Of Abiraterone

  2025cites this paper
• Synthesis of novel phenylalanine-coated copper nanoclusters for fluorescent probes to determine the interactions of cancer drugs with DNA.

  2024cites this paper
• The first RP-UHPLC method for simultaneous quantification of abiraterone acetate, its four degradants, and six specified process impurities and correct identification of all analytes based on molecular weight.

  2023cites this paper
• Sustainability as an Ethical Aspect of the Theory-Practice Gap in Business Schools

  2023cites this paper
• Evaluation of the RP-LC method for determining the pKa of abiraterone and its assay

  2023cites this paper
• Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasma.

  2023cites this paper
• Non-Thermal Plasma Review: Assessment and Improvement of Feasibility as a Retrofitted Technology in Tertiary Wastewater Purification

  2023cites this paper
• Academics Applying Interventionist Research to Deal with Wicked and Complex Societal Problems

  2023cites this paper
• Managing participation across boundaries: A typology for stakeholder engagement in the International Council for the Exploration of the Sea

  2023cites this paper
• Increasing the efficacy of abiraterone - from pharmacokinetics, through therapeutic drug monitoring to overcoming food effects with innovative pharmaceutical products.

  2022cites this paper
• Biotransformation of Abiraterone Into Five Characteristic Metabolites by the Rat Gut Microbiota and Liver Microsomes

  2022cites this paper
• Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects.

  2022cites this paper
• Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate

  2022cites this paper
• Developing a grounded practical theory of engaged communication scholarship: theorizing communities of practice in NCA journals

  2022cites this paper
• Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer

  2022influential citation
• The entrepreneurial role of waste companies in transforming waste streams to value streams: Lessons from a Danish Municipal waste company

  2022cites this paper
• Towards the essence of knowledge research: A comparative study ECKM papers 2017-2021

  2022cites this paper
• Determination of Abiraterone and Its Metabolites in Human Serum by LC-ESI-TOF/MS Using Solid-phase Extraction

  2021cites this paper
• Cryptosporidium: Host-Parasite Interactions and Pathogenesis

  2021cites this paper
• Making Knowledge Management Research more Scientific, Relevant, and Engaged: A Comparative Study of Academic ECKM Papers

  2021cites this paper
• Introduction: Sustainability Science as Co-Creative Research Praxis

  2021cites this paper
• Inhibition of Cytochrome P450 Enzymes by Drugs—Molecular Basis and Practical Applications

  2021cites this paper
• Researching Change and Changing: Integrating Collaboration and Action Through Interiority

  2021cites this paper
• Do‐it‐yourself as a means for making assistive technology accessible to elderly people: Evidence from the ICARE project

  2021cites this paper
• Experience as a catalyst of export destinations: The ambidextrous connection between international experience and past entrepreneurial experience

  2021cites this paper
• Closing the gap between scholarly knowledge and practice: Guidelines for HRM action research

  2020cites this paper
• Changing professional service archetypes in a law firm using Process Orientated Holonic (PrOH) Modelling

  2020cites this paper
• Knowledge Production in Organization Development: An Interiority-based Perspective

  2020cites this paper
• Sensemaking Reconsidered: Towards a broader understanding through phenomenology

  2020cites this paper
• Rediscovering Abductive Reasoning in Organization Development and Change Research

  2020cites this paper
• Managing interrelated tensions in headquarters–subsidiary relationships: The case of a multinational hybrid organization

  2020cites this paper
• A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone (D4A) in human plasma.

  2020cites this paper
• Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma.

  2020cites this paper
• Response of prostate cancer to addition of dutasteride after progression on abiraterone

  2020cites this paper
• Systematic Development and Validation of a RP-HPLC Method for Estimation of Abiraterone Acetate and its Degradation Products.

  2020cites this paper
• Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients.

  2020cites this paper
• How to Turn Around a Failing ERP Implementation: Project Management Routines as Boundary Objects

  2020cites this paper
• Managing interrelated tensions in headquarters–subsidiary relationships: The case of a multinational hybrid organization

  2020cites this paper
• Determinants of innovation performance

  2019cites this paper
• Beyond community engagement: centering research through Indigenous epistemologies and peoplehood

  2019cites this paper
• Development and validation of an UPLC-MS/MS method for the therapeutic drug monitoring of oral anti-hormonal drugs in oncology.

  2019cites this paper
• Engaged scholarship for environmental justice: A guide

  2019cites this paper
• Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients.

  2019cites this paper
• Discovering a Racemate Polycyclic Prenylated Acylphloroglucinol with Unprecedented Skeleton by an ESI-LCMS Analytical Approach.

  2019cites this paper
• HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer

  2018cites this paper
• The role of partnering in the transition to a circular economy in the Dutch infrastructure sector: A case study to the InnovA58

  2018cites this paper
• Armchair travelling the innovation journey : Building a narrative repertoire of the experiences of innovation project leaders

  2018cites this paper
• Moving from interdisciplinary research to transdisciplinary educational ethics: Bridging epistemological differences in researching higher education internationalization(s)

  2018cites this paper
• Bouncing Back from Failure: Entrepreneurial Resilience and the Internationalisation of Subsequent Ventures Created by Serial Entrepreneurs

  2018cites this paper
• Waging Peace Through Symphonic Discourse in the Sudan–Uganda Conflicts

  2018cites this paper
• Proactive behavior-based system for controlling safety risks in urban highway construction megaprojects

  2018cites this paper
• Quantitation of the anticancer drug abiraterone and its metabolite &Dgr;(4)‐abiraterone in human plasma using high‐resolution mass spectrometry

  2018cites this paper
• Chromatographic Methods for Determination of Drugs Used in Prostate Cancer in Biological and Pharmacological Samples

  2018cites this paper
• Engaged in digital service innovation

  2018cites this paper
• Simultaneous determination of selegiline, desmethylselegiline, R/S-methamphetamine, and R/S-amphetamine in oral fluid by LC/MS/MS

  2018cites this paper
• A PK/PD study of Delta‐4 abiraterone metabolite in metastatic castration‐resistant prostate cancer patients

  2018cites this paper
• High‐Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer

  2017cites this paper
• Determination of Novel Metabolites of Therapeutic Agents used in the Treatment of Castration-Resistant Prostate Cancer

  2017cites this paper
• Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.

  2017cites this paper
• Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities.

  2017influential citation
• Economic Assessment of Waterborne Outbreak of Cryptosporidiosis

  2017cites this paper
• Performance management of small water treatment plant operations: a decision support system

  2017cites this paper
• Redirecting abiraterone metabolism to fine tune prostate cancer anti-androgen therapy

  2016cites this paper
• Water Policy in Newfoundland and Labrador

  2015cites this paper
• Caractérisation du risque posé par les oocystes infectieux de Cryptosporidium de sources rurales et urbaines dans les eaux de surface

  2011cites this paper
• DEVELOPMENT OF THE HEALTHY RIVER ECOSYSTEM ASSESSMENT SYSTEM (THREATS) FOR INTEGRATED CHANGE ASSESSMENTS OF WATER QUALITY IN CANADIAN WATERSHEDS

  2011cites this paper
• Evaluation of Risk Assessment Tools to Predict Canadian Waterborne Disease Outbreaks

  2010cites this paper